|
Stephen K. Carter M.D. a Director of the Company since 2003 is the former Senior Vice President Clinical and Regulatory Affairs of Sugen Inc. (ownership of Sugen has since passed to Pfizer Inc. as part of its acquisition of Pharmacia in April 2003). Dr. Carter previously was the Senior Vice President Research and Development of Boehringer Ingelheim Pharmaceuticals Inc. now independently owned. Prior to this he served 13 years at Bristol-Myers Squibb Co. including as its Senior Vice President Worldwide Clinical Research and Development. Dr. Carter is a former Deputy Director at the National Cancer Institute (NCI)’s Division of Cancer Treatment and is a member of the American Society of Clinical Oncology. He received his Medical Doctorate from New York Medical College. He is currently a member of the boards of directors of Alfacell Corporation Achillion Pharmaceuticals Inc. Cytogen Corporation Sopherion Therapeutics Inc. and Vion Pharmaceuticals Inc.
| 